VAV1 |
VAV1, VAV: Proto-oncogene vav |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.263 |
Evidence |
|
EPB41L3 |
EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 |
PTPRZ1 |
IPI00291099 |
0.263 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
ETV6 |
ETV6, TEL, TEL1: Transcription factor ETV6 |
0.263 |
Evidence |
|
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
0.263 |
Evidence |
|
ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.263 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.263 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
ETF1 |
ETF1, ERF1, RF1, SUP45L1: Eukaryotic peptide chain release factor subunit 1 |
0.263 |
Evidence |
|
ELAVL1 |
ELAVL1, HUR: ELAV-like protein 1 |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
0.263 |
Evidence |
|
ITGB7 |
ITGB7: Integrin beta-7 precursor |
ELMO2 |
ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 |
0.263 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
0.263 |
Evidence |
|
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
ZFYVE16 |
ZFYVE16, KIAA0305: Zinc finger FYVE domain-containing protein 16 |
0.263 |
Evidence |
|
EDD1 |
EDD1, EDD, HYD, KIAA0896: E3 ubiquitin-protein ligase EDD1 |
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
0.263 |
Evidence |
|
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.263 |
Evidence |
|
CD63 |
CD63, MLA1, TSPAN30: CD63 antigen |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.263 |
Evidence |
|
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
PSD |
TYL: TYL protein |
0.263 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.263 |
Evidence |
|
LPXN |
LPXN, LDLP: Leupaxin |
MYH9 |
MYH9: Myosin-9 |
0.263 |
Evidence |
|
EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
CUL5 |
CUL5, VACM1: Cullin-5 |
0.263 |
Evidence |
|
ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
0.263 |
Evidence |
|
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
DPF2 |
DPF2, REQ, UBID4: Zinc finger protein ubi-d4 |
0.263 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
0.263 |
Evidence |
O
|
MYH9 |
MYH9: Myosin-9 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
0.263 |
Evidence |
|
XPO1 |
XPO1, CRM1: Exportin-1 |
RBM8A |
RBM8A, RBM8, HSPC114, MDS014: RNA-binding protein 8A |
0.263 |
Evidence |
|
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.263 |
Evidence |
|
EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
0.263 |
Evidence |
|